VCM
CLB icon

Versant Capital Management’s Core Laboratories CLB Stock Holding History

Versant Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Sell
967
-285
-23% -$4.07K ﹤0.01% 2193
2026
Q1 		$21K Sell
1,252
-265
-17% -$4.74K ﹤0.01% 1796
2025
Q4 		$24.3K Buy
1,517
+616
+68% +$9.17K ﹤0.01% 1522
2025
Q3 		$11.1K Buy
901
+777
+627% +$9.11K ﹤0.01% 1889
2025
Q2 		$1.43K Buy
+124
New +$1.47K ﹤0.01% 2442
2025
Q1 		– Sell
-466
Closed -$8.07K – 2537
2024
Q4 		$8.07K Buy
+466
New +$8.99K ﹤0.01% 1520
2024
Q1 		– Sell
-21
Closed -$371 – 1890
2023
Q4 		$371 Buy
+21
New +$423 ﹤0.01% 1748
2023
Q1 		– Sell
-151
Closed -$3.06K – 1770
2022
Q4 		$3.06K Buy
151
+133
+739% +$2.58K ﹤0.01% 1032
2022
Q3 		$0 Sell
18
-77
-81% -$1.3K ﹤0.01% 1450
2022
Q2 		$2K Hold
95
– – ﹤0.01% 1074
2022
Q1 		$3K Hold
95
– – ﹤0.01% 1018
2021
Q4 		$2K Hold
95
– – ﹤0.01% 1104
2021
Q3 		$3K Sell
95
-42
-31% -$1.28K ﹤0.01% 1025
2021
Q2 		$5K Buy
137
+119
+661% +$4.27K ﹤0.01% 887
2021
Q1 		$1K Hold
18
– – ﹤0.01% 1327
2020
Q4 		$0 Sell
18
-229
-93% -$4.68K ﹤0.01% 1359
2020
Q3 		$3K Buy
247
+15
+6% +$315 ﹤0.01% 963
2020
Q2 		$4K Buy
+232
New +$4.16K ﹤0.01% 889
2020
Q1 		– Sell
-62
Closed -$2K – 1347
2019
Q4 		$2K Hold
62
– – ﹤0.01% 1124
2019
Q3 		$2K Sell
62
-66
-52% -$3.07K ﹤0.01% 1148
2019
Q2 		$6K Buy
128
+121
+1,729% +$7.1K ﹤0.01% 894
2019
Q1 		$0 Sell
7
-25
-78% -$1.68K ﹤0.01% 1580
2018
Q4 		$1K Hold
32
– – ﹤0.01% 1338
2018
Q3 		$3K Hold
32
– – ﹤0.01% 1206
2018
Q2 		$4K Buy
32
+6
+23% +$730 ﹤0.01% 1127
2018
Q1 		$2K Buy
26
+7
+37% +$775 ﹤0.01% 1263
2017
Q4 		$2K Sell
19
-17
-47% -$1.7K ﹤0.01% 1315
2017
Q3 		$3K Sell
36
-53
-60% -$5.14K ﹤0.01% 1151
2017
Q2 		$9K Buy
89
+56
+170% +$6.04K 0.01% 892
2017
Q1 		$3K Sell
33
-5
-13% -$581 ﹤0.01% 1142
2016
Q4 		$4K Sell
38
-3
-7% -$332 ﹤0.01% 1049
2016
Q3 		$4K Sell
41
-4
-9% -$461 ﹤0.01% 1029
2016
Q2 		$5K Sell
45
-1
-2% -$121 ﹤0.01% 951
2016
Q1 		$5K Sell
46
-24
-34% -$2.49K ﹤0.01% 939
2015
Q4 		$7K Buy
+70
New +$8.01K ﹤0.01% 832

Other funds holding CLB

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Versant Capital Management's CLB Position: Q2 2026 in Review

Versant Capital Management reduced its Core Laboratories (CLB) stake by 23% in Q2 2026, selling an estimated $4.07K and leaving 967 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Versant Capital Management first reported a position in CLB in Q4 2015 and has held it in 35 quarters since. The position peaked at $24.3K in Q4 2025. 11 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Versant Capital Management held 967 shares of Core Laboratories worth $11.3K as of Q2 2026.
  • Versant Capital Management sold 285 Core Laboratories shares in Q2 2026, an estimated $4.07K.
  • Core Laboratories made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2193 holding.
  • Versant Capital Management first reported a position in Core Laboratories in Q4 2015 and has held it in 35 quarters since.
  • Versant Capital Management's Core Laboratories position peaked at $24.3K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.